KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $42.9 million.

  • Charles River Laboratories International's Change in Accured Expenses rose 37.56% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.2 million, marking a year-over-year increase of 412.97%. This contributed to the annual value of -$27.6 million for FY2024, which is 321.77% down from last year.
  • Per Charles River Laboratories International's latest filing, its Change in Accured Expenses stood at $42.9 million for Q3 2025, which was up 80.72% from $23.7 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Change in Accured Expenses ranged from a high of $51.3 million in Q2 2021 and a low of -$79.8 million during Q1 2022.
  • For the 3-year period, Charles River Laboratories International's Change in Accured Expenses averaged around $6.1 million, with its median value being $13.8 million (2023).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 563.47% in 2023, then tumbled by 188.33% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Change in Accured Expenses (Quarterly) stood at $26.1 million in 2021, then slumped by 136.14% to -$9.4 million in 2022, then tumbled by 69.58% to -$16.0 million in 2023, then tumbled by 60.23% to -$25.6 million in 2024, then spiked by 37.56% to $42.9 million in 2025.
  • Its last three reported values are $42.9 million in Q3 2025, $23.7 million for Q2 2025, and $15.3 million during Q1 2025.